Medical treatment of type 2 diabetes mellitus: Recommendations of the Diabetes, Obesity and Nutrition Group of the Spanish Society of Internal Medicine

Revista clínica española
F J Carrasco-Sánchezen representación del Grupo de trabajo de Diabetes, Obesidad y Nutrición de la Sociedad Española de Medicina Interna

Abstract

Type 2 diabetes mellitus is a major health problem with high prevalence, morbidity and mortality, and its medical treatment is growing in complexity due to patients' diverse clinical conditions. This article presents a consensus document by the Diabetes, Obesity and Nutrition Group of the Spanish Society of Internal Medicine, with recommendations for the medical treatment of type 2 diabetes mellitus. The main objective of this article is to facilitate the therapeutic decision-making process to improve the care of patients with diabetes. The document prioritises treatments with cardiovascular benefits, especially those that benefit patients with heart and renal failure.

References

Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Dec 19, 2008·The New England Journal of Medicine·William DuckworthUNKNOWN VADT Investigators
Jun 13, 2012·The New England Journal of Medicine·Hertzel C GersteinSalim Yusuf
Mar 20, 2014·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Antonio ZapateroRaquel Barba
May 6, 2015·Annals of Internal Medicine·Pierluigi CostanzoStephen L Atkin
May 13, 2015·European Journal of Internal Medicine·Javier EnaUNKNOWN Diabetes and Obesity Working Group of the Spanish Society of Internal Medicine
Sep 18, 2015·The New England Journal of Medicine·Bernard ZinmanUNKNOWN EMPA-REG OUTCOME Investigators
Feb 18, 2016·The New England Journal of Medicine·Walter N KernanUNKNOWN IRIS Trial Investigators
Mar 24, 2016·Journal of the American Geriatrics Society·Alan J SinclairGary Meininger
Jun 14, 2016·The New England Journal of Medicine·Steven P MarsoUNKNOWN LEADER Trial Investigators
Sep 17, 2016·The New England Journal of Medicine·Steven P MarsoUNKNOWN SUSTAIN-6 Investigators
Jun 13, 2017·The New England Journal of Medicine·Steven P MarsoUNKNOWN DEVOTE Study Group
Jun 13, 2017·The New England Journal of Medicine·Bruce NealUNKNOWN CANVAS Program Collaborative Group
Jan 26, 2018·Revista clínica española·R Gómez-HuelgasJ Ena
Nov 13, 2018·The New England Journal of Medicine·Stephen D WiviottUNKNOWN DECLARE–TIMI 58 Investigators
Nov 19, 2018·Revista clínica española·A Zapatero-GaviriaR Barba-Martín
Feb 28, 2019·Revista clínica española·A Zapatero-GaviriaF J Elola-Somoza
Apr 17, 2019·The New England Journal of Medicine·Vlado PerkovicUNKNOWN CREDENCE Trial Investigators
Apr 25, 2019·Indian Journal of Endocrinology and Metabolism·Awadhesh Kumar Singh, Ritu Singh
Jul 20, 2019·Therapeutic Advances in Chronic Disease·Olusola F OnoviranMukaila A Raji
Sep 20, 2019·The New England Journal of Medicine·John J V McMurrayUNKNOWN DAPA-HF Trial Committees and Investigators
Sep 20, 2019·JAMA : the Journal of the American Medical Association·Julio RosenstockUNKNOWN CAROLINA Investigators
Nov 2, 2019·Metabolism: Clinical and Experimental·Golnaz RanjbarAmirhossein Sahebkar

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.